ARRIVENT
Live / Registered — Registered (as of 05 Aug 2025)
What this means for you
Registered since 05 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98228980
- Registration number
- 7877640
- Mark type
- Stylized text
- Filed
- 18 Oct 2023
- Published for opposition
- 31 Dec 2024
- Registered
- 05 Aug 2025
- Attorney of record
- Wade Savoy
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of lung cancer
- Class 042 — Scientific and technological services: research and development in the pharmaceutical and biotechnology fields
Owner
- ArriVent BioPharma, Inc., Newtown Square, PA, US
- ArriVent BioPharma, Inc., Newtown Square, PA, US
- ArriVent BioPharma, Inc., Newtown Square, PA, US
Prosecution history
- 05 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
- 10 Jul 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 30 Jan 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 31 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Dec 2024 — PUBLISHED FOR OPPOSITION
- 25 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Dec 2024 — USE AMENDMENT ACCEPTED
- 04 Dec 2024 — AMENDMENT TO USE PROCESSING COMPLETE
- 04 Dec 2024 — USE AMENDMENT FILED
- 04 Dec 2024 — TEAS AMENDMENT OF USE RECEIVED
- 04 Dec 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Dec 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Dec 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED